![Quiver Logo](/static/img/logo-icon.png)
![CGEM logo](https://quiver-logos.s3.us-east-2.amazonaws.com/cgem.png)
Cullinan Therapeutics, Inc. Common Stock
Cullinan Therapeutics Inc is a biopharmaceutical company. It has diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, create differentiated ideas, identify the appropriate targets, and select the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view CGEM Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of CGEM by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CGEM's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to CGEM
Recent picks made for CGEM stock on CNBC
ETFs with the largest estimated holdings in CGEM
Flights by private jets registered to CGEM
![Quiver Logo](/static/img/logo-icon.png)